The C-X-C Chemokine Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the C-X-C Chemokine Receptor Type 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Oncology, Respiratory, Immunology, and Metabolic Disorders which include the indications Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Triple-Negative Breast Cancer (TNBC), Acute Respiratory Distress Syndrome, Community Acquired Pneumonia, Liver Transplant Rejection, Pancreatic Islet Transplant Rejection, and Type 1 Diabetes (Juvenile Diabetes). It also reviews key players involved in C-X-C Chemokine Receptor Type 1 targeted therapeutics development with respective active and dormant or discontinued products.
The C-X-C Chemokine Receptor Type 1 pipeline targets constitutes close to five molecules. Out of which, approximately five molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, and Phase I stages are 2, 2, and 1 respectively.
C-X-C Chemokine Receptor Type 1 overview
C-X-C Chemokine Receptor Type 1 is a receptor for interleukin 8 (IL8). It binds to IL8 with high affinity, and transduces the signal through a G-protein-activated second messenger system. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. This receptor binds to IL-8 with a high affinity and to MGSA (GRO) with a low affinity.
For a complete picture of C-X-C Chemokine Receptor Type 1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.